Depression Severe
12
4
4
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.3%
1 terminated out of 12 trials
85.7%
-0.9% vs benchmark
17%
2 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (12)
The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis
Kintsugi Voice Device Pilot Study
Kintsugi Voice Device Pivotal Study
Telehealth Behavioral Activation for Teens
Exercise Recovery From Persistent Depression: A Thematic Analysis
Brain Stimulation for Severe Depression
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Depression
Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department
Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)
Integrated Depression Care
Outcomes Associated With Suicidality in Inpatients With Symptoms of Depression (OASIS-D)
Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department